PRIMED-AI: Academic-Industrial Partnerships (UG3/UH3 Clinical Trial Optional)
ID: 359270Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359270
Timeline
    Description

    The National Institutes of Health (NIH) is announcing an upcoming funding opportunity titled "PRIMED-AI: Academic-Industrial Partnerships (UG3/UH3 Clinical Trial Optional)" aimed at developing innovative AI-based tools that integrate clinical imaging with multimodal health data to enhance personalized medicine for patients with chronic conditions. This initiative will focus on fostering collaborations between academic institutions and industry partners to improve data integration and interoperability, followed by algorithm development and performance testing in a subsequent phase. The estimated total program funding is $2.9 million, with applications expected to open in July 2025 and close in November 2025, while the anticipated award date is September 2026. Interested parties can reach out to Dr. Sahana N. Kukke at ODPRIMED-AI@od.nih.gov or by phone at 301-402-3756 for further information.

    Point(s) of Contact
    Sahana N. Kukke, PhD Office of the Director/NIH Common Fund, DPCPSI, OD
    (301) 402-3756
    ODPRIMED-AI@od.nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    PRIMED-AI: Translating Models to Clinic (UG3/UH3 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity titled "PRIMED-AI: Translating Models to Clinic," aimed at developing innovative AI-based tools that integrate clinical imaging with multimodal health data to enhance personalized medicine for patients with chronic conditions. This initiative, part of the Precision Medicine with Artificial Intelligence program, will utilize a biphasic mechanism focusing initially on rigorous AI model building through the analysis of large datasets, with successful projects advancing to evaluate the clinical utility of AI-driven Clinical Decision Support tools. The estimated total program funding is $10.2 million, with applications expected to be solicited after the synopsis posting on July 1, 2025, and a closing date anticipated on November 1, 2025. Interested applicants can contact Dr. Sahana N. Kukke at ODPRIMED-AI@od.nih.gov or by phone at 301-402-3756 for further information.
    PRIMED-AI: Multi-use Framework Playbooks (UG3 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "PRIMED-AI: Multi-use Framework Playbooks," aimed at supporting the development of AI-based tools that integrate clinical imaging with various health data types to enhance personalized medicine. This initiative seeks to fund projects that will create "playbooks" for the responsible use of PRIMED-AI models, focusing on error mitigation, data management, and regulatory preparation. With an estimated total program funding of $650,000, the opportunity is open to small businesses, and while applications are not currently being solicited, interested parties are encouraged to prepare for collaboration and project development ahead of the anticipated synopsis posting on July 1, 2025. For further inquiries, potential applicants can contact Dr. Sahana N. Kukke at ODPRIMED-AI@od.nih.gov or by phone at 301-402-3756.
    PRIMED-AI: Logistics Center (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "PRIMED-AI: Logistics Center," aimed at developing innovative AI-based tools that integrate clinical imaging with various health data types to enhance personalized medicine for patients with chronic health conditions. This initiative will establish a Logistics Center that provides administrative infrastructure through three integrated cores—Administration, Evaluation, and Outreach—to manage consortium activities, including governance, workshops, and community engagement. The estimated total program funding is $2,750,000, with applications not currently being solicited; however, potential applicants are encouraged to prepare for collaboration and project development ahead of the anticipated Notice of Funding Opportunity (NOFO) release on July 1, 2025. For further inquiries, interested parties may contact Dr. Sahana N. Kukke at 301-402-3756 or via email at ODPRIMED-AI@od.nih.gov.
    PRIMED-AI: Validation Center (U54 Clinical Trial Not Allowed) 
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing the upcoming opportunity for the PRIMED-AI: Validation Center program, which aims to develop AI-based tools that integrate clinical imaging with various health data types to enhance personalized medicine for patients with chronic conditions. This initiative will serve as an independent hub for the verification, validation, and uncertainty quantification of AI-enabled Clinical Decision Support (CDS) tools, focusing on the systematic retesting and harmonization of deliverables to characterize their performance comprehensively. The program is particularly relevant for small businesses with expertise in the validation of CDS tools, and while applications are not currently being solicited, interested parties are encouraged to prepare for future submissions. The estimated total program funding is $3,900,000, with key dates including a synopsis post date of July 1, 2025, and an estimated award date of September 1, 2026. For further inquiries, contact Sahana N. Kukke, PhD, at ODPRIMED-AI@od.nih.gov or call 301-402-3756.
    Notice of Intent to Publish a Funding Opportunity Announcement for Biomedical-engineering Partnership with Industry (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity for the Biomedical-engineering Partnership with Industry (U01 Clinical Trial Not Allowed) aimed at fostering collaborations between academic and industrial organizations to develop innovative biomedical solutions. This initiative encourages the establishment of robust engineering solutions to address significant biomedical challenges, requiring applicants to form strategic alliances and outline a detailed plan with specific milestones to achieve results within 5-10 years. The anticipated funding opportunity announcement is expected to be published in February 2022, with applications due by May 2022, and the estimated award date is set for April 1, 2023. For further inquiries, interested parties can contact Dr. I. George Zubal at 301-827-5168 or via email at igeorge.zubal@nih.gov.
    Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), is offering a funding opportunity titled "Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)." This initiative aims to foster interdisciplinary research teams that can translate scientific discoveries into practical tools and methods for diagnosing and treating diseases, addressing both clinical and non-clinical challenges. The program is particularly significant for enhancing cancer research and improving patient care outcomes, with a maximum funding amount of $499,000 per year available for projects lasting up to five years. Applications will be accepted starting January 5, 2025, with a closing date of January 8, 2028. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-337.html.
    Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)" aimed at fostering collaborative research partnerships between academic and industrial investigators to accelerate the development of innovative bioengineering tools and technologies. The program seeks to establish multidisciplinary teams that apply a quantitative bioengineering approach to address significant biomedical challenges, with a focus on creating robust solutions that can enhance life science understanding and medical practices within a 5-10 year timeframe. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, and for-profit entities, particularly those emphasizing diversity in research. Interested parties should note that the application deadline is September 7, 2027, and for further inquiries, they can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information page at https://grants.nih.gov/grants/guide/pa-files/PAR-24-325.html.
    Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)." This initiative aims to foster collaborations between academic and industrial entities to develop innovative solutions for critical health challenges, particularly in the fields of cancer and eye health. The program encourages interdisciplinary research teams to enhance and validate technologies that improve diagnostic methods and treatment capabilities, ultimately supporting better health outcomes for diverse populations. The funding amount is capped at $499,000 annually, with a maximum project duration of five years. Initial submissions are due by January 5, 2025, and interested applicants can find more information at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)" aimed at supporting innovative research in the development of therapeutic and diagnostic devices for disorders affecting the nervous or neuromuscular systems. This cooperative agreement program encourages investigators to conduct translational activities and clinical feasibility studies, with a focus on advancing medical device technology through collaboration with NIH resources for design, testing, and regulatory support. The initiative is particularly significant as it seeks to accelerate the clinical introduction of medical technologies, ultimately improving patient outcomes while adhering to best practices in research and development. Interested applicants, including various eligible institutions and organizations, must submit their proposals by January 28, 2028, and can find more information at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems," aimed at fostering collaborations between academic institutions and industrial organizations to enhance imaging technologies for cancer diagnosis and treatment. This initiative seeks to translate scientific discoveries and engineering advancements into practical tools that address significant challenges in cancer research, focusing on the development and validation of imaging systems that improve detection and treatment monitoring. The grant offers a maximum budget of $500,000 per year for up to five years, with applications required to include at least one academic and one industrial investigator. Interested applicants can find more information and submit their proposals by the deadline of January 7, 2027, by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-259.html.